Clinical Trial Update: The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating how sequential tau protein and amyloid plaque imaging changes relate to stroke prognosis and cognitive outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Dementia
• Vascular Mild Cognitive Impairment

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Post-stroke Dementia, Vascular Mild Cognitive Impairment | Phase 2 | Status: UNKNOWN